Liquid Biopsy
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
12,952
NCT04006405
AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC
Phase: N/A
Role: Lead Sponsor
Start: Jan 10, 2020
Completion: May 7, 2025
NCT05060783
Renal Cancer Detection With Liquid Biopsy
Role: Collaborator
Start: Jul 1, 2021
Completion: Jul 1, 2027
NCT05028660
AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study
Start: Jul 21, 2021
Completion: Apr 30, 2025
NCT05235009
LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in Asymptomatic Adults (LEV87A)
Start: Feb 1, 2022
Completion: Dec 31, 2026
NCT05295017
LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in High-Risk Adults (LEV93A)
Start: Mar 14, 2022
Completion: Mar 31, 2026
NCT06044532
SKAMo-1: Characterization of the Upper Layers of Skin
Start: Mar 1, 2023
Completion: Apr 27, 2023
NCT05780957
Multi-Cancer Early Detection (MCED) of Firefighters
Start: Mar 21, 2023
Completion: Dec 31, 2030
NCT06035367
SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes
Start: Jul 6, 2023
Completion: Oct 30, 2023
Loading map...